Citadel Advisors’s Enlivex Ltd ENLV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$22.4K Sell
1,607
-33
-2% -$522 ﹤0.01% 12645
2025
Q4
$17.3K Buy
+1,640
New +$24.5K ﹤0.01% 12370
2025
Q3
Sell
-5,273
Closed -$88.6K 13074
2025
Q2
$88.6K Buy
5,273
+2,320
+79% +$34.5K ﹤0.01% 11421
2025
Q1
$43K Buy
2,953
+2,166
+275% +$36K ﹤0.01% 12467
2024
Q4
$13.8K Sell
787
-600
-43% -$11.7K ﹤0.01% 13431
2024
Q3
$34.9K Buy
1,387
+314
+29% +$6.39K ﹤0.01% 12292
2024
Q2
$22.9K Buy
1,073
+1,060
+8,154% +$28.1K ﹤0.01% 12517
2024
Q1
$758 Sell
13
-494
-97% -$24.1K ﹤0.01% 14255
2023
Q4
$20.5K Buy
507
+407
+407% +$10.4K ﹤0.01% 12600
2023
Q3
$2.37K Sell
100
-287
-74% -$9.93K ﹤0.01% 13730
2023
Q2
$15.3K Sell
387
-373
-49% -$15.6K ﹤0.01% 12957
2023
Q1
$41.5K Sell
760
-4,420
-85% -$266K ﹤0.01% 12396
2022
Q4
$303K Sell
5,180
-12,200
-70% -$787K ﹤0.01% 9301
2022
Q3
$1.11M Buy
17,380
+16,200
+1,373% +$1.18M ﹤0.01% 6780
2022
Q2
$80K Buy
+1,180
New +$91.4K ﹤0.01% 11592
2022
Q1
Sell
-1,467
Closed -$138K 13819
2021
Q4
$138K Sell
1,467
-553
-27% -$65.1K ﹤0.01% 12373
2021
Q3
$299K Buy
2,020
+1,147
+131% +$168K ﹤0.01% 11067
2021
Q2
$117K Sell
873
-207
-19% -$31.1K ﹤0.01% 12773
2021
Q1
$180K Sell
1,080
-940
-47% -$194K ﹤0.01% 11828
2020
Q4
$255K Buy
+2,020
New +$325K ﹤0.01% 9355

Other funds holding ENLV

Citadel Advisors's ENLV Position: Q1 2026 in Review

Citadel Advisors increased its Enlivex Ltd (ENLV) stake by 9.3% in Q1 2026, buying an estimated $2.5K and bringing the position to 1,864 shares worth $26K. The position accounts for ﹤0.01% of the portfolio, ranked #12616.

Citadel Advisors first reported a position in ENLV in Q3 2016 and has held it in 14 quarters since. The position peaked at $232K in Q4 2022. 34 funds tracked by Wall St. Rank hold ENLV as of Q1 2026.

  • Citadel Advisors held 1,864 shares of Enlivex Ltd worth $26K as of Q1 2026.
  • Citadel Advisors bought 158 Enlivex Ltd shares in Q1 2026, an estimated $2.5K.
  • Enlivex Ltd made up ﹤0.01% of Citadel Advisors's portfolio in Q1 2026, its #12616 holding.
  • Citadel Advisors first reported a position in Enlivex Ltd in Q3 2016 and has held it in 14 quarters since.
  • Citadel Advisors's Enlivex Ltd position peaked at $232K in Q4 2022.
  • 34 funds tracked by Wall St. Rank held Enlivex Ltd as of Q1 2026.

Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.